Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Randall RE, Williamson Jr WC, Mullinax F, Tung NY, Still WJ . Manifestations of systemic light chain deposition. Am J Med 1976; 60: 293–299.
Heilman RL, Velosa JA, Holley KE, Offord KP, Kyle RA . Long-term follow-up and response to chemotherapy in patients with light-chain deposition disease. Am J Kidney Dis 1992; 20: 34–41.
Royer B, Arnulf B, Martinez F, Roy L, Flaguel B, Etienne I et al. High dose chemotherapy in light chain or light and heavy chain deposition disease. Kidney Int 2004; 65: 642–648.
Firkin F, Hill PA, Dwyer K, Gock H . Reversal of dialysis-dependent renal failure in light-chain deposition disease by autologous peripheral blood stem cell transplantation. Am J Kidney Dis 2004; 44: 551–555.
Pozzi C, D'Amico M, Fogazzi GB, Curioni S, Ferrario F, Pasquali S et al. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. Am J Kidney Dis 2003; 42: 1154–1163.
Terashima K, Takahashi K, Kojima M, Imai Y, Tsuchida S, Migita S et al. Kappa-type light chain crystal storage histiocytosis. Acta Pathol Jpn 1978; 28: 111–138.
Lebeau A, Zeindl-Eberhart E, Muller EC, Muller-Hocker J, Junbult PR, Emmerich B et al. Generalized crystal-storing histiocytosis associated with monoclonal gammopathy: molecular analysis of a disorder with rapid clinical course and review of the literature. Blood 2002; 100: 1817–1827.
Welschof M, Terness P, Kolbinger F, Zewe M, Dubel S, Dorsam H et al. Amino acid sequence based PCR primers for amplification of rearranged human heavy and light chain immunoglobulin variable region genes. J Immunol Methods 1995; 179: 203–214.
Lossos IS, Tibshirani R, Narasimhan B, Levy R . The inference of antigen selection on Ig genes. J Immunol 2000; 165: 5122–5126.
Lin J, Markowitz GS, Valeri AM, Kambham N, Sherman WH, Appel GB et al. Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol 2001; 12: 1482–1492.
Sethi S, Cuiffo BP, Pinkus GS, Rennke HG . Crystal-storing histiocytosis involving the kidney in a low-grade B-cell lymphoproliferative disorder. Am J Kidney Dis 2002; 39: 183–188.
Foster SJ, Brezinschek HP, Brezinschek RI, Lipsky PE . Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM+ B cells. J Clin Invest 1997; 99: 1614–1627.
Deret S, Chomilier J, Huang D, Preud'homme JL, Stevens FJ, Aucouturier P et al. Molecular modeling of immunoglobulin light chains implicates hydrophobic residues in non-amyloid light chain deposition disease. Protein Eng 1997; 10: 1191–1197.
Cogne M, Preud'homme JL, Bauwens M, Touchard G, Aucouturier P . Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease. J Clin Invest 1991; 87: 2186–2190.
Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 2003; 348: 1875–1883.
Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med 1996; 335: 91–97.